Clinical Trials Browser

NCT01920737 2025-09-16

A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

Phase 2 Active not recruiting

39 enrolled

Other hematologic neoplasm

Leukemia

NCT06055790 2025-09-03

Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

Phase 2 Recruiting

20 enrolled

CNS

Brain Neoplasms

NCT03314636 2025-08-08

CONPET

Phase 2 Active not recruiting

53 enrolled

Plasma cell

Neoplasms, Plasma Cell

NCT06067503 2025-04-22

Biomarkers to Detect Endocrine Therapy Resistance

Phase 2 Recruiting

8 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

NCT03824535 2025-04-09

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

Phase 2 Completed

15 enrolled 7 charts

Smoking Cessation, Multiple Pulmonary Nodules

NCT03092518 2025-02-19

Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology

Phase 2 Completed

27 enrolled 13 charts

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

NCT03615664 2025-01-16

BURGUND

Phase 2 Completed

115 enrolled

Lymphoid

Hodgkin Disease, Lymphoma

NCT01390584 2023-06-29

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Phase 2 Terminated

6 enrolled 9 charts

Lymphoid

Hodgkin Disease, Lymphoma

NCT04121507 2023-05-24

ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy

Phase 2 Completed

60 enrolled

Lymphoid

Lymphoma, B-Cell, Lymphoma, T-Cell

NCT04467281 2022-07-01

A Study of PET/CT Scans With the Radioactive Tracer 89Zr-DFO-Daratumumab in People With Myeloma

Phase 2 Withdrawn

Plasma cell

Multiple Myeloma

NCT03271281 2022-06-30

PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2

Phase 2 Completed

113 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT03278275 2022-06-30

PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105

Phase 2 Completed

116 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT02559115 2021-05-18

68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer

Phase 2 Completed

19 enrolled 5 charts

Genitourinary

Prostatic Neoplasms

NCT03125629 2021-04-09

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

Phase 2 Completed

53 enrolled 8 charts

Cancer Diagnosis

NCT03791905 2021-03-23

PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma

Phase 2 Unknown

216 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT02611882 2020-12-22

PSMA PET

Phase 2 Completed

225 enrolled 12 charts

Genitourinary

Prostatic Neoplasms

NCT02964988 2019-10-15

uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

Phase 2 Terminated

17 enrolled

Genitourinary

Prostate Cancer Metastatic

NCT02681640 2017-04-06

uPAR PET/CT for Preoperative Staging of Breast Cancer Patients

Phase 2 Completed

50 enrolled

Breast

Breast Neoplasms

NCT03008694 2017-01-02

Effect of FDG-PET/CT for Simulation and Radiation Treatment Planning in Oral Cancer Patients

Phase 2 Unknown

100 enrolled

Head & Neck

Mouth Neoplasms

NCT02002455 2016-10-21

Flucipro

Phase 2 Completed

26 enrolled

Genitourinary

Prostatic Neoplasms

NCT00254683 2009-04-14

Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer

Phase 2 Unknown

100 enrolled

Gastrointestinal

Rectal Neoplasms